tiprankstipranks
Autolus Therapeutics (AUTL)
NASDAQ:AUTL
AUTL
Autolus Therapeutics
RESEARCH TOOLSreports
Want to see AUTL full AI Analyst Report?

Autolus Therapeutics (AUTL) Revenue

949 Followers
StatisticsMarket CapRevenue

Autolus Therapeutics Revenue

Autolus Therapeutics had a revenue of 24.25M in the quarter ending Dec 31, 2025, with 14.44%. This bring the company's revenue in the last twelve months to 75.35M, Decreased 47.38%. In the fiscal year ending Dec 31, 2025, Autolus Therapeutics had annual revenue of 75.56M with 646.68% growth.
Revenue (ttm)
75.35M
Revenue Growth
645.87%
P/S Ratio
5.53
Revenue/Employee
$116,792
Employees
647
Market Cap
$417.84M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
75.56M65.44M+646.68%
Dec 31, 2024
10.12M8.42M+496.00%
Dec 31, 2023
1.70M-4.50M-72.59%
Dec 31, 2022
6.19M4.69M+311.02%
Dec 31, 2021
1.51M-208.00K-12.13%
Dec 31, 2020
1.72M-1.19M-41.02%
Dec 31, 2019
2.91M1.86M+178.19%
Sep 30, 2018
1.05M-647.66K-38.25%
Sep 30, 2017
1.69M――